Page last updated: 2024-08-21

aminoimidazole carboxamide and Astrocytoma, Grade IV

aminoimidazole carboxamide has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cloughesy, TF; Czernin, J; Dang, J; Guo, D; Hildebrandt, IJ; Mazzotta, MM; Mischel, PS; Phelps, M; Prins, RM; Radu, CG; Shyy, JY; Soto, H; Watson, AD1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Astrocytoma, Grade IV

ArticleYear
The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis.
    Proceedings of the National Academy of Sciences of the United States of America, 2009, Aug-04, Volume: 106, Issue:31

    Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Glioblastoma; Humans; Lipogenesis; Mice; Protein Kinases; PTEN Phosphohydrolase; Ribonucleotides; Ribosomal Protein S6 Kinases; Ribosomal Protein S6 Kinases, 90-kDa; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2009